MicroRNA-613 regulates the expression of brain-derived neurotrophic factor in Alzheimer's disease

BioScience Trends

Volumn 10, Issue 5, 2016, Pages 372-377

  Li, Wei ^a   Li, Xu ^a   Xin, Xin ^a   Kan, Peng Cheng ^a   Yan, Yan ^a  

^a TIANJIN HUANHU HOSPITAL   (China)

Author keywords

APP PS1 mice; Dementia of Alzheimer's type; Mild cognitive impairment; MiRNAs

Indexed keywords

3' UNTRANSLATED REGION; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; MICRORNA;

3' UNTRANSLATED REGION; AGED; ALZHEIMER DISEASE; ANIMAL; CELL LINE; COGNITIVE DEFECT; FEMALE; GENETICS; HIPPOCAMPUS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUSE; TRANSGENIC MOUSE;

3' UNTRANSLATED REGIONS; AGED; ALZHEIMER DISEASE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE; COGNITIVE DYSFUNCTION; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, TRANSGENIC; MICRORNAS; MIDDLE AGED;

EID: 84996931642     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2016.01127     Document Type: Article

References (28)

1. Alzheimer's Association. 2015 Alzheimer's disease facts and figures. Alzheimers Dement. 2015; 11:332-384
2. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007; 3:186-191
3. Aicardi G, Argilli E, Cappello S, Santi S, Riccio M, Thoenen H, Canossa M. Induction of long-term potentiation and depression is reflected by corresponding changes in secretion of endogenous brain-derived neurotrophic factor. Proc Natl Acad Sci U S A. 2004; 101:15788-15792
4. Poo MM. Neurotrophins as synaptic modulators. Nat Rev Neurosci. 2001; 2:24-32
5. Ferrer I, Marín C, Rey MJ, Ribalta T, Goutan E, Blanco R, Tolosa E, Martí E. BDNF and full length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol. 1999; 58:729-739
6. Nagata T, Kobayashi N, Ishii J, Shinagawa S, Nakayama R, Shibata N, Kuerban B, Ohnuma T, Kondo K, Arai H, Yamada H, Nakayama K. Association between DNA methylation of the BDNF promoter region and clinical presentation in Alzheimer's disease. Dement Geriatr Cogn Dis Extra. 2015; 5:64-73
7. Vilardo E, Barbato C, Ciotti M, Cogoni C, Ruberti F. MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem. 2010; 285:18344-18351
8. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 2008; 28:1213-1223
9. Absalon S, Kochanek DM, Raghavan V, Krichevsky AM. MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons. J Neurosci. 2013; 33:14645-14659
10. Banzhaf-Strathmann J, Benito E, May S, Arzberger T, Tahirovic S, Kretzschmar H, Fischer A, Edbauer D. MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease. EMBO J. 2014; 33:1667-1680
11. Alzheimer's Association. 2011 Alzheimer's disease facts and figures. Alzheimers Dement. 2011; 7:208-244
12. Zhang XY, Liang J, Chen da C. Xiu MH, Yang FD, Kosten TA, Kosten TR. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology (Berl). 2012; 222:277-284
13. Meng D, Li Z, Ma X, Fu L, Qin G. MicroRNA-1280 modulates cell growth and invasion of thyroid carcinoma through targeting estrogen receptor a. Cell Mol Biol (Noisy-le-grand). 2016; 62:1-6
14. Wang W, Zhang Y, Zhu B, Duan T, Xu Q, Wang R, Lu L, Jiao Z. Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis. Oncotarget. 2015; 6:42557-42568
15. Thome AD, Harms AS, Volpicelli-Daley LA, Standaert DG. microRNA-155 regulates Alpha-Synuclei-induced inflammatory response in models of Parkinson disease. J Neurosci. 2016; 36:2383-2390
16. Mushtaq G, Greig NH, Anwar F, Zamzami MA, Choudhry H, Shaik MM, Tamargo IA, Kamal MA. miRNAs as circulating biomarkers for Alzheimer's disease and Parkinson's disease. Med Chem. 2016; 12:217-225
17. Mezache L, Mikhail M, Garofalo M, Nuovo GJ. Reduced miR-512 and the elevated expression of its targets cFLIP and MCL1 localize to neurons with hyperphosphorylated Tau protein in Alzheimer disease. AppI Immunohistochem Mol Morphol. 2015; 23:615-623
18. Zong Y, Yu P, Cheng H, Wang H, Wang X, Liang C, Zhu H, Qin Y, Qin C. miR-29c regulates NAV3 protein expression in a transgenic mouse model of Alzheimer's disease. Brain Res. 2015; 1624:95-102
19. Song J, Lee JE. miR-155 is involved in Alzheimer's disease by regulating T lymphocyte function. Front Aging Neurosci. 2015; 7:61
20. Li D, Li DQ, Liu D, Tang XJ. MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer. Cell Oncol (Dordr). 2016; 39:139-147
21. Zhang X, Zhang H. Diminished miR-613 expression as a novel prognostic biomarger for humal ovarian cancer. Eur Rev Med Pharmacol Sci. 2016; 20:837-841
22. Zhong D, Zhang Y, Zeng YJ, Gao M, Wu GZ, Hu CJ, Huang G, He FT. MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRa. Lipids Health Dis. 2013; 12:32
23. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors. 2004; 22:123-131
24. Acheson A, Conover JC, Fandl JP, DeChiara TM, Russell M, Thadani A, Squinto SP, Yancopoulos GD, Lindsay RM. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature. 1995; 374:450-453
25. Huang EJ, Reichardt LF. Neurotrophins: Roles in neuronal development and function. Ann Rev Neurosci. 2001; 24:677-736
26. Mughal MR, Baharani A, Chigurupati S, Son TG, Chen E, Yang P, Okun E, Arumugam T, Chan SL, Mattson MP. Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice. Hum Mol Genet. 2011; 20:659-669
27. Sohrabji F, Lewis DK. Estrogen-BDNF interactions: Implications for neurodegenerative diseases. Front Neuroendocrinol. 2006; 27:404-414
28. Scalzo P, Kummer A, Bretas TL, Cardoson F, Teixeira AL. Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease. J Neurol. 2010; 257:540-545